Andreas Wicki, Director at Pacira BioSciences, Inc. (PCRX), sold 138,710 shares at $73.10 ($10.2M) on 2021-03-12, disclosed to the SEC on 2021-03-16.
Open-market sale of $10.2M PCRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $73.10 | 58,754 | $4.3M | 42.3% |
| 2 | $73.10 | 58,754 | $4.3M | 42.3% |
| 3 | $73.68 | 10,601 | $781K | 7.7% |
| 4 | $73.68 | 10,601 | $781K | 7.7% |
| Total | $73.19 avg | 138,710 | $10.2M | 100% |
| Filing → |
| HRMY | SELL | 2022-11-16 | $6.1M | — | Filing → |
| HRMY | SELL | 2022-11-10 | $15.2M | — | Filing → |
| HRMY | SELL | 2022-11-04 | $68.2M | — | Filing → |